nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bibliometric analysis of the Cheminformatics/QSAR literature (2000–2023) for predictive modeling in data science using the SCOPUS database
|
Banerjee, Arkaprava |
|
|
29 |
4 |
p. 3703-3715 |
artikel |
2 |
A 4D tensor-enhanced multi-dimensional convolutional neural network for accurate prediction of protein–ligand binding affinity
|
Huang, Dingfang |
|
|
29 |
4 |
p. 3041-3058 |
artikel |
3 |
Advancing antimalarial drug discovery: ensemble machine learning models for predicting PfPK6 inhibitor activity
|
Gholami, Maryam |
|
|
29 |
4 |
p. 3575-3586 |
artikel |
4 |
AI and ML for small molecule drug discovery in the big data era III
|
Roy, Kunal |
|
|
29 |
4 |
p. 2863 |
artikel |
5 |
AI-DPAPT: a machine learning framework for predicting PROTAC activity
|
Abouzied, Amr S. |
|
|
29 |
4 |
p. 2995-3007 |
artikel |
6 |
A multiscale molecular structural neural network for molecular property prediction
|
Shi, Zhiwei |
|
|
29 |
4 |
p. 3273-3292 |
artikel |
7 |
A multitask interpretable model with graph attention mechanism for activity prediction of low-data PIM inhibitors
|
Wang, Zixiao |
|
|
29 |
4 |
p. 3101-3112 |
artikel |
8 |
ASS1 is a hub gene and possible therapeutic target for regulating metabolic dysfunction-associated steatotic liver disease modulated by a carbohydrate-restricted diet
|
Chen, Shaojun |
|
|
29 |
4 |
p. 3717-3732 |
artikel |
9 |
Cangrelor and AVN-944 as repurposable candidate drugs for hMPV: analysis entailed by AI-driven in silico approach
|
Thaikkad, Amritha |
|
|
29 |
4 |
p. 3587-3605 |
artikel |
10 |
Classification models and SAR analysis of anaplastic lymphoma kinase (ALK) inhibitors using machine learning algorithms with two data division methods
|
Qu, Dan |
|
|
29 |
4 |
p. 2919-2943 |
artikel |
11 |
Computational screening of umami tastants using deep learning
|
Dutta, Prantar |
|
|
29 |
4 |
p. 2979-2993 |
artikel |
12 |
Correction: Machine learning-based activity prediction of phenoxy-imine catalysts and its structure–activity relationship study
|
Zhou, Xiaoke |
|
|
29 |
4 |
p. 3423 |
artikel |
13 |
Deep learning in the discovery of antiviral peptides and peptidomimetics: databases and prediction tools
|
Nawaz, Maryam |
|
|
29 |
4 |
p. 3753-3788 |
artikel |
14 |
Discovery of novel potential 11β-HSD1 inhibitors through combining deep learning, molecular modeling, and bio-evaluation
|
Chen, Xiaodie |
|
|
29 |
4 |
p. 3485-3500 |
artikel |
15 |
Drug repurposing to identify potential FDA-approved drugs targeting three main angiogenesis receptors through a deep learning framework
|
Torabi, Mohammadreza |
|
|
29 |
4 |
p. 3637-3659 |
artikel |
16 |
Dual inhibition of AChE and MAO-B in Alzheimer’s disease: machine learning approaches and model interpretations
|
Hou, Qinghe |
|
|
29 |
4 |
p. 3113-3130 |
artikel |
17 |
Enhancing PI3Kγ inhibitor discovery: a machine learning-based virtual screening approach integrating pharmacophores, docking, and molecular descriptors
|
Jia, Lei |
|
|
29 |
4 |
p. 3661-3678 |
artikel |
18 |
Explainable AI-driven prediction of APE1 inhibitors: enhancing cancer therapy with machine learning models and feature importance analysis
|
Iqbal, Aga Basit |
|
|
29 |
4 |
p. 3371-3390 |
artikel |
19 |
First report on analysis of chemical space, scaffold diversity, critical structural features of HDAC11 inhibitors
|
Bhagat, Rinki Prasad |
|
|
29 |
4 |
p. 3679-3702 |
artikel |
20 |
General structure-activity relationship models for the inhibitors of Adenosine receptors: A machine learning approach
|
Janbozorgi, M. |
|
|
29 |
4 |
p. 3253-3272 |
artikel |
21 |
Generative adversarial network (GAN) model-based design of potent SARS-CoV-2 Mpro inhibitors using the electron density of ligands and 3D binding pockets: insights from molecular docking, dynamics simulation, and MM-GBSA analysis
|
Chakraborty, Annesha |
|
|
29 |
4 |
p. 3059-3075 |
artikel |
22 |
GraphkmerDTA: integrating local sequence patterns and topological information for drug-target binding affinity prediction and applications in multi-target anti-Alzheimer’s drug discovery
|
Zhang, Zuolong |
|
|
29 |
4 |
p. 3147-3164 |
artikel |
23 |
HDAC3_VS_assistant: cheminformatics-driven discovery of histone deacetylase 3 inhibitors
|
Tinkov, Oleg V. |
|
|
29 |
4 |
p. 3165-3187 |
artikel |
24 |
iDCNNPred: an interpretable deep learning model for virtual screening and identification of PI3Ka inhibitors against triple-negative breast cancer
|
Jaiswal, Ravishankar |
|
|
29 |
4 |
p. 3077-3100 |
artikel |
25 |
Identification and validation of oxidative stress-related diagnostic markers for recurrent pregnancy loss: insights from machine learning and molecular analysis
|
Hu, Hui |
|
|
29 |
4 |
p. 2881-2897 |
artikel |
26 |
Identification of STAT3 phosphorylation inhibitors using generative deep learning, virtual screening, molecular dynamics simulations, and biological evaluation for non-small cell lung cancer therapy
|
Cai, Weiji |
|
|
29 |
4 |
p. 3189-3205 |
artikel |
27 |
Identify critical genes of breast cancer and corresponding leading natural product compounds of potential therapeutic targets
|
Fan, Xiaokai |
|
|
29 |
4 |
p. 3009-3022 |
artikel |
28 |
Integrated AI and machine learning pipeline identifies novel WEE1 kinase inhibitors for targeted cancer therapy
|
Chandrasekaran, Jaikanth |
|
|
29 |
4 |
p. 3425-3448 |
artikel |
29 |
Integrated machine learning-based virtual screening and biological evaluation for identification of potential inhibitors against cathepsin K
|
Parwez, Shahid |
|
|
29 |
4 |
p. 2865-2880 |
artikel |
30 |
Integrating deep learning and molecular dynamics simulations for FXR antagonist discovery
|
Yang, Yueying |
|
|
29 |
4 |
p. 3391-3409 |
artikel |
31 |
Integrating machine learning and structural dynamics to explore B-cell lymphoma-2 inhibitors for chronic lymphocytic leukemia therapy
|
Bharadwaj, Rima |
|
|
29 |
4 |
p. 3233-3252 |
artikel |
32 |
Integrating traditional QSAR and read-across-based regression models for predicting potential anti-leishmanial azole compounds
|
Nandi, Rajat |
|
|
29 |
4 |
p. 3207-3231 |
artikel |
33 |
Interpretable drug-target affinity prediction based on pre-trained models’ output as embeddings and based on structure-aware cross-attention for feature fusion
|
Zheng, Fang |
|
|
29 |
4 |
p. 3537-3554 |
artikel |
34 |
Leveraging machine learning to predict drug permeation: impact of menthol and limonene as enhancers
|
Yadav, Manisha |
|
|
29 |
4 |
p. 3131-3146 |
artikel |
35 |
Machine learning and cheminformatics-based Identification of lichen-derived compounds targeting mutant PBP4R200L in Staphylococcus aureus
|
Mathpal, Shalini |
|
|
29 |
4 |
p. 3345-3370 |
artikel |
36 |
Machine learning approaches for predicting the small molecule–miRNA associations: a comprehensive review
|
Panghalia, Ashish |
|
|
29 |
4 |
p. 3825-3856 |
artikel |
37 |
Machine learning-based activity prediction of phenoxy-imine catalysts and its structure–activity relationship study
|
Zhou, Xiaoke |
|
|
29 |
4 |
p. 3411-3422 |
artikel |
38 |
Machine learning-based screening and molecular simulations for discovering novel PARP-1 inhibitors targeting DNA repair mechanisms for breast cancer therapy
|
Shahab, Muhammad |
|
|
29 |
4 |
p. 3323-3343 |
artikel |
39 |
Machine learning models to identify lead compound and substitution optimization to have derived energetics and conformational stability through docking and MD simulations for sphingosine kinase 1
|
Dhanabalan, Anantha Krishnan |
|
|
29 |
4 |
p. 2945-2977 |
artikel |
40 |
Machine learning, network pharmacology, and molecular dynamics reveal potent cyclopeptide inhibitors against dengue virus proteins
|
Imam, Mohammed A. |
|
|
29 |
4 |
p. 2899-2917 |
artikel |
41 |
Machine learning: Python tools for studying biomolecules and drug design
|
Ryzhkov, Fedor V. |
|
|
29 |
4 |
p. 3789-3824 |
artikel |
42 |
MedKG: enabling drug discovery through a unified biomedical knowledge graph
|
Kumari, Madhavi |
|
|
29 |
4 |
p. 3465-3483 |
artikel |
43 |
Optimizing kinase and PARP inhibitor combinations through machine learning and in silico approaches for targeted brain cancer therapy
|
Poustforoosh, Alireza |
|
|
29 |
4 |
p. 3293-3303 |
artikel |
44 |
PPARγ modulator predictor (PGMP_v1): chemical space exploration and computational insights for enhanced type 2 diabetes mellitus management
|
Amin, Sk. Abdul |
|
|
29 |
4 |
p. 3305-3321 |
artikel |
45 |
Probing the dark chemical matter against PDE4 for the management of psoriasis using in silico, in vitro and in vivo approach
|
Swapna, B. |
|
|
29 |
4 |
p. 3449-3464 |
artikel |
46 |
Python tools for structural tasks in chemistry
|
Ryzhkov, Fedor V. |
|
|
29 |
4 |
p. 3733-3752 |
artikel |
47 |
QMGBP-DL: a deep learning and machine learning approach for quantum molecular graph band-gap prediction
|
Abbassi, Outhman |
|
|
29 |
4 |
p. 3501-3515 |
artikel |
48 |
“Several birds with one stone”: exploring the potential of AI methods for multi-target drug design
|
Mukaidaisi, Muhetaer |
|
|
29 |
4 |
p. 3023-3039 |
artikel |
49 |
Targeting Poly (ADP-ribose) polymerase-1 (PARP-1) for DNA repair mechanism through QSAR-based virtual screening and MD simulation
|
Cao, Kun |
|
|
29 |
4 |
p. 3517-3535 |
artikel |
50 |
Titania: an integrated tool for in silico molecular property prediction and NAM-based modeling
|
Koutroumpa, Nikoletta-Maria |
|
|
29 |
4 |
p. 3555-3573 |
artikel |
51 |
Unraveling potent Glycyrrhiza glabra flavonoids as AKT1 inhibitors using network pharmacology and machine learning-assisted QSAR
|
Niharika, Desu Gayathri |
|
|
29 |
4 |
p. 3607-3635 |
artikel |